Anaphylactic shock during SpaceOAR Vue hydrogel procedure.

Urol Case Rep

Department of Urology, Detroit Medical Center, 4160 John R St., Harper Professional Building, Suite 1021, Detroit, MI, 48201, United States.

Published: November 2024

In this report, we present a unique and rare case of an intraoperative anaphylactic shock leading to cardiac arrest during the SpaceOAR Vue™ hydrogel procedure in a 70-year-old patient undergoing External Beam Radiation Therapy (EBRT) for advanced localized prostate cancer. To our knowledge, this is the first urologic case report documenting this adverse reaction associated with the placement of the SpaceOAR Vue product. We discuss the possible culprits, including the hydrogel's polyethylene glycol (PEG) and iodine content, perioperative antibiotics, and local lidocaine anesthetic, and propose relevant considerations for clinicians administering rectal hydrogel spacers.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11550147PMC
http://dx.doi.org/10.1016/j.eucr.2024.102870DOI Listing

Publication Analysis

Top Keywords

anaphylactic shock
8
spaceoar vue
8
hydrogel procedure
8
shock spaceoar
4
vue hydrogel
4
procedure report
4
report unique
4
unique rare
4
rare case
4
case intraoperative
4

Similar Publications

To study a case of Kounis syndrome (KS) type II, characterized by allergy, myocardial infarction, and ventricular fibrillation. A patient diagnosed with KS type II was admitted to Yangpu Hospital, School of Medicine, Tongji University in 2021. After systemic treatment, routine investigations, including blood tests, electrocardiography (ECG), and biochemical and coagulation analyses, were performed.

View Article and Find Full Text PDF

Introduction: Simulation has become an integral part of healthcare education. Studies demonstrate rapid knowledge and skill acquisition with the use of simulation and rapid knowledge degradation if it is not further reinforced. Effect of simulation on metacognitive processes, or the ability to understand one's own knowledge, is not well-investigated yet.

View Article and Find Full Text PDF

Diclofenac etalhyaluronate, an active pharmaceutical ingredient in JOYCLU (JCL), serves as a joint function improvement agent in knee and hip osteoarthritis patients. However, frequent cases of anaphylaxis induced by JCL administration have been reported. Recent clinical research suggests the potential utility of the basophil activation test (BAT) in predicting JCL-induced anaphylaxis.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!